New Zealand markets closed

Calidi Biotherapeutics, Inc. (CLDI)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.1900-0.1100 (-36.67%)
At close: 04:00PM EDT
0.1944 +0.00 (+2.32%)
After hours: 07:59PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
1,949
372
2,137
420
Total cash
1,949
372
2,137
420
Other current assets
225
303
603
93
Total current assets
4,303
786
2,740
513
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
6,336
1,717
975
999
Accumulated depreciation
-993
-631
-390
-276
Net property, plant and equipment
5,343
1,086
585
723
Other long-term assets
143
725
66
616
Total non-current assets
5,716
1,811
651
1,339
Total assets
10,019
2,597
3,391
1,852
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
807
5,425
5,002
4,942
Accounts payable
2,796
2,124
510
822
Accrued liabilities
5,432
5,347
3,506
1,537
Other current liabilities
-
29,830
16,691
1,100
Total current liabilities
10,232
42,989
25,959
8,888
Non-current liabilities
Long-term debt
2,060
-
-
6,371
Other long-term liabilities
2,038
-
-
-
Total non-current liabilities
8,022
10,048
9,044
15,444
Total liabilities
18,254
53,037
35,003
24,332
Stockholders' equity
Common stock
4
2
2
2
Retained earnings
-99,572
-70,356
-44,929
-34,437
Accumulated other comprehensive income
-47
-14
-1
6
Total stockholders' equity
-8,235
-50,440
-31,612
-22,480
Total liabilities and stockholders' equity
10,019
2,597
3,391
1,852